Cognitive & Nootropic / side effects and safety / Last reviewed 2026-06-02

NA-Semax-Amidate Side Effects: Safety Signals and Warnings

NA-Semax-Amidate safety concerns are compound-specific. The main listed side effects are Headache (extrapolated from Semax), Mild nasal irritation (intranasal), and Dizziness (rare). The main warning signals are No direct human clinical trials exist for NA-Semax-Amidate, Safety and efficacy data extrapolated from Semax research, and Dual modification may create unpredictable pharmacological differences.

Read the full NA-Semax-Amidate guide Browse answer pages

Direct Answer

Evidence for NA-Semax-Amidate is too preliminary to support a research protocol with confidence. Like N-Acetyl Selank, this is a modified derivative of a Russian peptide with no independent clinical trials. The parent Semax has only Russian-sourced data. Cerebrolysin is a far better-evidenced starting point for cognitive enhancement research.

Evidence grade
Level D
Research status
Early Research
Category
Cognitive & Nootropic
Best for
Modified ACTH-analog cognitive peptide research (no independent clinical data)

Reported Side Effects

Warnings

Known or Plausible Interactions

Regulatory Context

Unregulated research peptide in most countries.

Evidence Snapshot

Evidence gradeLevel D
Research statusEarly Research
Best supported outcomesCognitive Enhancement (extrapolated from Semax) (Level D), Enhanced Metabolic Stability (Level D), and Neuroprotection (extrapolated) (Level D)
Primary citation count3
Last reviewed2026-06-02

Related Guides

How to Cite This Page

ExaminePeptides. "NA-Semax-Amidate Side Effects: Safety Signals and Warnings." Last reviewed 2026-06-02. https://examinepeptides.com/answers/na-semax-amidate-side-effects-safety/

This static answer page is built for fast indexing and direct citation. It summarizes the matching full evidence review and links back to primary sources where the source database includes them.